Alberto
Carmona Bayonas
Asociado Ciencias de la Salud
Institute Catalá Oncología
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Institute Catalá Oncología (15)
2024
-
Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry
Gastric Cancer, Vol. 27, Núm. 1, pp. 131-145
-
Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON–SEOM registry
Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1674-1686
-
State of the scientific evidence and recommendations for the management of older patients with gastric cancer
Journal of Geriatric Oncology, Vol. 15, Núm. 3
2023
-
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy
Therapeutic Advances in Medical Oncology, Vol. 15
2022
-
Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial
Thrombosis and haemostasis, Vol. 122, Núm. 10, pp. 1653-1661
2021
-
External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry
Therapeutic Advances in Medical Oncology, Vol. 13
-
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
Gastric Cancer, Vol. 24, Núm. 2, pp. 445-456
-
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry
Gastric Cancer, Vol. 24, Núm. 4, pp. 926-936
-
Olaratumab-induced Biomarker Modulation in Sarcomas—Letter
Molecular Cancer Therapeutics
2020
-
Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry
PloS one, Vol. 15, Núm. 7, pp. e0235848
2018
-
Factors Predicting Adherence to a Tailored-Dose Adjuvant Treatment on the Basis of Geriatric Assessment in Elderly People With Colorectal Cancer: A Prospective Study
Clinical Colorectal Cancer, Vol. 17, Núm. 1, pp. e59-e68
-
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: The ANICE-PaC study
BMC Cancer, Vol. 18, Núm. 1
2017
-
Supportive care in pancreatic ductal adenocarcinoma
Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1293-1302
2016
-
Management of infection and febrile neutropenia in patients with solid cancer
Clinical and Translational Oncology, Vol. 18, Núm. 6, pp. 557-570
-
Outpatient management of cancer-associated pulmonary embolism (PE): analysis of lung carcinoma (LC) cohort from the Epiphany study
Annals of Oncology, Vol. 27, pp. vi513